Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A.

Cristina NovembrinoMassimo Boscolo AnzolettiMaria Elisa MancusoSho ShinoharaFlora Peyvandi

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2019)

BIOPHEN™ FVIII:C showed good analytical performance and diagnostic accuracy and could be considered suitable for the introduction in routine analytical panel of coagulation for the diagnosis of HA patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
high throughput
patient reported outcomes
mass spectrometry
liquid chromatography